Jupiter Neurosciences, Inc.

US$2.20As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:JUNSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (1888.70%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (97.95%)
Mkt cap US$2.901M
ROIC (420.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.48
12.56%
170.65%
Hold 11|9|3|4|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
32.44%
36.26%
36.57%
32.09%
Revenue$M
0.196
0.200
0.195
0.205
13.79%
10.75%
4.97%
9.96%
Peers (US$2.901M)
Cap (US$)
PE
3.015M
—
2.990M
—
2.745M
—
Capital
TTM
5Y
10Y
Leveragex
1.024
0.225
0.233
EBIT/Intx
1.228
0.536
0.601
Own earn%
51.09
88.44
70.38
Sh yield%
19.83
15.72
13.65
Owners
Insiders/Inst%
2.82
45.60
Short interest%
5.19
SBC / revenue%
1.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
6